Arkolith/Insider Trading/CINC/Form 4

Freeman Mason

EVP Clinical DevelopmentCinCor Pharma, Inc. (CINC) · full profile →Form 4 · filed Jan 13, 2022
Net Buying
Open-Market Buys
$42K
Open-Market Sells
$0
Net Open-Market Flow
$42K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 11, 2022Buy(P)100$16.00$2K100
Jan 11, 2022Buy(P)3K$16.00$40K3K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-003188) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML